Implanon NXT® subdermal implant

DEVICE2 trials

Sponsors

University Hospital, Geneva, Maíta Poli de Araújo

Conditions

ContraceptionMenstrual SymptomsProgestogen Adverse Reaction

Early Phase 1

Body Composition and Sport Performance Among Young Female Soccer Players Using Subdermic Etonogestrel

SuspendedNCT06775626

Maíta Poli de AraújoMenstrual Symptoms

Start: 2025-04-01End: 2025-12-31Target: 40Updated: 2025-08-14

Unknown Phase

Does Oral Desogestrel Prior to Insertion of the Etonogestrel Subdermal Implant Improve Continuation Rate at One Year?

TerminatedNCT05174195

University Hospital, GenevaContraception, Progestogen Adverse Reaction

Start: 2016-08-15End: 2019-09-30Updated: 2021-12-30

Related Papers

Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial

BMC Research Notes2023-03-134 citations